1. Home
  2. TBLA vs NBTX Comparison

TBLA vs NBTX Comparison

Compare TBLA & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Taboola.com Ltd.

TBLA

Taboola.com Ltd.

HOLD

Current Price

$4.63

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$22.04

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBLA
NBTX
Founded
2007
2003
Country
United States
France
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
TBLA
NBTX
Price
$4.63
$22.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$4.80
$8.00
AVG Volume (30 Days)
1.7M
30.9K
Earning Date
11-05-2025
09-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$1,880,771,000.00
$11,930,711.00
Revenue This Year
$11.25
N/A
Revenue Next Year
$5.55
$145.24
P/E Ratio
$58.27
N/A
Revenue Growth
10.96
N/A
52 Week Low
$2.50
$2.82
52 Week High
$4.64
$30.35

Technical Indicators

Market Signals
Indicator
TBLA
NBTX
Relative Strength Index (RSI) 74.89 56.96
Support Level $3.93 $21.67
Resistance Level $4.22 $23.68
Average True Range (ATR) 0.13 0.90
MACD 0.05 -0.02
Stochastic Oscillator 97.42 69.46

Price Performance

Historical Comparison
TBLA
NBTX

About TBLA Taboola.com Ltd.

Taboola.com Ltd is a technology company that powers recommendations across the Open Web with an artificial intelligence-based, algorithmic engine. It partners with websites, devices, and mobile apps, collectively referred to as digital properties, to recommend editorial content and advertisements on the Open Web. Geographically it serves Israel, the United Kingdom, United States, Germany, Rest of the world. It generates the majority of its revenue from the United States.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: